Clincosm LogoSign in Get a demo

locally advanced gastric adenocarcinoma

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

Anti-PD-1 Antibody Combined With Chemotherapy for Neoadjuvant

Active, not recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • PD-1
  • DNA panel and RNA Sequencing
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Diseases
Aug 17, 2022

Locally Advanced Gastric Adenocarcinoma Trial in Xi'an (Tislelizumab combined with Oxaliplatin and Capecitabine)

Active, not recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Tislelizumab combined with Oxaliplatin and Capecitabine
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Diseases
Aug 17, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Locally Advanced Gastric Adenocarcinoma Trial in Tianjin (PD-1 antibody combined with FOLFIRINOX regimen, PD-1 antibody combined

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • PD-1 antibody combined with FOLFIRINOX regimen
  • PD-1 antibody combined with SOX program
  • Tianjin, Tianjin, China
    RuiLiu
May 27, 2021

Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma Trial in Shanghai (Camrelizumab plus mFLOT regimen, R0

Unknown status
  • Metastatic Gastric Cancer
  • Locally Advanced Gastric Adenocarcinoma
  • Camrelizumab plus mFLOT regimen
  • R0 surgery
  • Shanghai, Shanghai, China
    Fudan University, Shanghai Cancer Center
Aug 11, 2020